$ADCTADC Therapeutics SA

📅 Upcoming

🕒 Recent(90d)

News

• Out of sight, out of work? What’s driving remote job cuts
  Biopharma professionals sometimes find themselves out of jobs when employers want to bring staff back into the office, as recently seen at biotech EMD Serono and Exelixis.
  biospace · 23h ago
• Kolon TissueGene cuts 37 US staffers after Phase 3 fail
  Follow along as BioSpace tracks job cuts and restructuring initiatives.
  biospace · 1d ago
• MapLight presses the pause button; ADC Therapeutics considers what to do with Zynlonta
  ⏸️ MapLight Therapeutics pauses preclinical and discovery work: The biotech said it will instead focus its resources on advancing its lead candidate, ML-007C-MA, for schizophrenia and Alzheimer’s d…
  endpoints · 6d ago
• An ADC specialist sinks on safety concerns for blood cancer drug
  Shares for ADC Therapeutics fell more than 50% after a Phase 3 trial observed a death rate that at least one analyst believes “may be difficult to accept for physicians, patients and regulators.”
  biopharma_dive · 2mo ago
• ADC Therapeutics' confirmatory data for Zynlonta muddied by death rates
  ADC Therapeutics’ bid to secure full approval for Zynlonta in relapsed or refractory diffuse large B-cell lymphoma has been complicated by death rates in its confirmatory trial. The company said ...
  endpoints · 2mo ago
• Fierce Biotech Layoff Tracker 2026: Kolon cuts workforce after ph. 3 fail; Sanofi sheds 229 staffers
  As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.
  fiercebiotech · 8mo ago